Brain tumour clinical trial title

PARADIGM - OlaPArib And RADiotherapy In newly-diagnosed GlioblastoMa

Brain tumour type

Glioblastoma, 

Website

www.cancerresearchuk.org/science/research/who-and-what-we-fund/browse-by-location/glasgow/university-of-glasgow/grants/anthony-chalmers-17870-cruk-13-034-paradigm-olaparib-and-radiotherapy

Description:

Short-course radiotherapy plus olaparib for newly diagnosed in patients unsuitable for radical chemoradiation: a randomised phase II clinical trial preceded by a lead-in phase I dose escalation study.

Date added: 16th August 2015

Open/Closed: Open

Trial ends: Aug 2018

Provider

Cancer Research UK Clinical Trials Unit Glasgow

Contact details

Karen Allan :
Gartnavel General Hospital Campus
42 Shelley Court
Glasgow
G12 0XD
E-mail: karen.wilson@glasgow.ac.uk
Telephone: 0141 301 7959

Find on Google maps »